Is health impact assessment useful in the context of trade negotiations? A case study of the trans pacific partnership agreement

BMJ Open

Volumn 6, Issue 4, 2016, Pages 855-4425

  Hirono, Katherine ^a   Haigh, Fiona ^a   Gleeson, Deborah ^b   Harris, Patrick ^c   Thow, Anne Marie ^c   Friel, Sharon ^d  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b LA TROBE UNIVERSITY   (Australia)

^c University of Sydney   (Australia)

^d AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL ABSTINENCE; ARTICLE; CASE STUDY; FOOD PACKAGING; HEALTH CARE POLICY; HEALTH IMPACT ASSESSMENT; HUMAN; OUTCOME ASSESSMENT; TOBACCO; VULNERABLE POPULATION; AUSTRALIA AND NEW ZEALAND; COMMERCIAL PHENOMENA; INTERNATIONAL COOPERATION; INTERPERSONAL COMMUNICATION; PUBLIC HEALTH; WESTERN HEMISPHERE;

AMERICAS; AUSTRALASIA; COMMERCE; HEALTH IMPACT ASSESSMENT; HUMANS; INTERNATIONAL COOPERATION; NEGOTIATING; PUBLIC HEALTH;

EID: 84969983913     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2015-010339     Document Type: Article

References (97)

1. Friel S, Gleeson D, Thow AM, et al. A new generation of trade policy: potential risks to diet-related health from the trans pacific partnership agreement. Global Health 2013;9:46.
2. Thow AM, Snowdon W, Labonté R, et al. Will the next generation of preferential trade and investment agreements undermine prevention of noncommunicable diseases? A prospective policy analysis of the Trans Pacific Partnership Agreement. Health Policy 2015;119:88-96.
3. Baum FE, Anaf JM. Transnational corporations and health: A research agenda. Int J Health Serv 2015;45:353-62.
4. Gleeson D, Friel S. Emerging threats to public health from regional trade agreements. Lancet 2013;381:1507-9.
5. Department of Foreign Affairs and Trade (DFAT). Trans-Pacific Partnership Agreement Overview. http://www.dfat.gov.au/fta/tpp/tpp-overview.pdf.
6. Unitaid. The trans-pacific partnership agreement: implications for access to medicines and public health. Genenva: Unitaid World Health Organisation, 2014.
7. Australian Medical Association. TPP fears despite Govt assurances. 2015. https://ama.com.au/ausmed/tpp-fears-despite-govt-assurances.
8. Medecins Sans Frontieres. Briefing note: Trading away health: The Trans-Pacific Partnership Agreement (TPP) 2015. 2015. http://www.msfaccess.org/content/briefing-note-trading-away-health-transpacific-partnership-agreement-tpp-2015.
9. Office of the High Commissioner for Human Rights. UN experts voice concern over adverse impact of free trade and investment agreements on human rights 2 June 2015. http://www.ohchr.org/EN/NewsEvents/Pages/DisplayNews.aspx?NewsID=16031&LangID=E.
10. Harris P, Gleeson D. Assessing the impact of the Trans-Pacific Partnership Agreement on the health of Australians. Aust N Z J Public Health 2014;38:496-6.
11. World Health Organisation (WHO). Closing the gap in a generation. Geneva: Comission on Social Determinants of Health, 2008.
12. Bacigalupe A, Esnaola S, Martín U, et al. Learning lessons from past mistakes: how can Health in All Policies fulfil its promises? J Epidemiol Community Health 2010;64:504-5.
13. Collins J, Koplan JP. Health impact assessment: A step toward health in all policies. JAMA 2009;302:315-17.
14. Haigh F, Baum F, Dannenberg AL, et al. The effectiveness of health impact assessment in influencing decision-making in Australia and New Zealand 2005-2009. BMC Public Health 2013;13:1188.
15. Kemm J. Past achievement, current understanding and future progress in health impact assessment. Oxford: Oxford University press, 2013.
16. Haigh F, Harris E, Chok HNG, et al. Characteristics of health impact assessments reported in Australia and New Zealand 2005-2009. Aust N Z J Public Health 2013;37:534-46.
17. Blau J, Ernst K, Wismar M, et al. The use of health impact assessment across Europe. In: Ståhl T, Wismar M, Ollila E, et al., eds. Health in all policies: prospects and potentials. Helsinki: Ministry of Social Affairs and Health, 2006:209-30.
18. Dannenberg AL, Bhatia R, Cole BL, et al. Use of health impact assessment in the U.S: 27 case studies, 1999-2007. Am J Prev Med 2008;34:241-56.
19. Pope J, Bond A, Morrison-Saunders A, et al. Advancing the theory and practice of impact assessment: setting the research agenda. Environ Impact Assesst Rev 2013;41:1-9.
20. Harris-Roxas B, Harris E. Differing forms, differing purposes: A typology of health impact assessment. Environ Impact Assess Rev 2011;31:396-403.
21. Kingdon JW, Thurber JA. Agendas, alternatives, and public policies. 2nd edn. Pearson, 2010.
22. Shiffman J, Smith S. Generation of political priority for global health initiatives: A framework and case study of maternal mortality. Lancet 2007;370:1370-9.
23. Buse K, Mays N, Walt G. Making health policy. McGraw-Hill Education (UK), 2012.
24. Harris P, Sainsbury P, Kemp L. The fit between health impact assessment and public policy: practice meets theory. Soc Sci Med 2014;108:46-53.
25. Harris P, Harris-Roxas B, Harris E, et al. Health Impact Assessment: A practical guide. Sydney: Centre for Health Equity Training, Research and Evaluation, Part of the UNSW Research Centre for Primary Health Care and Equity, 2007, pp 13-17.
26. Flynn S, Baker B, Kaminski M, et al. The U.S. proposal for an intellectual property chapter in the trans-pacific partnership agreement. Am University Int Law Rev 2012;28:105-202.
27. Department of Health and Ageing-Medicines Australia. Trends in and drivers of Pharmaceutical Benefits Scheme expenditure: Report for the Access to Medicines Working Group. Department of Health and Ageing, 2013.
28. Lehnbom EC, Boxall A-M, Russell LM, et al. Management of medicines in chronic illness: views of community pharmacists in New South Wales. Journal of Pharmacy Practice & Research 2009;39: 207-10.
29. Schoen C, Osborn R, How SK, et al. In chronic condition: experiences of patients with complex health care needs, in eight countries, 2008. Health Aff (Millwood) 2009;28:w1-w16.
30. Searles A, Doran E, Faunce TA, et al. The affordability of prescription medicines in Australia: Are copayments and safety net thresholds too high? Aust Health Rev 2013;37:32-40.
31. Doran E, Robertson J, Salkeld G. Pharmaceutical Benefits Scheme cost sharing, patient cost consciousness and prescription affordability. Aust Health Rev 2011;35:37-44.
32. Jatrana S, Crampton P, Norris P. Ethnic differences in access to prescription medication because of cost in New Zealand. J Epidemiol Community Health 2011;65:454-60.
33. Kemp A, Roughead E, Preen D, et al. Determinants of self-reported medicine underuse due to cost: A comparison of seven countries. J Health Serv Res Policy 2010;15:106-14.
34. Essue B, Kelly P, Roberts M, et al. We can't afford my chronic illness! The out-of-pocket burden associated with managing chronic obstructive pulmonary disease in western Sydney, Australia. J Health Serv Res Policy 2011;16:226-31.
35. Stocks N, Ryan P, Allan J, et al. Gender, socioeconomic status, need or access? Differences in statin prescribing across urban, rural and remote Australia. Aust J Rural Health 2009;17:92-6.
36. Gadkari AS, McHorney CA. Medication nonfulfillment rates and reasons: narrative systematic review. Curr Med Res Opin 2010;26:683-705.
37. Kiil A, Houlberg K. How does copayment for health care services affect demand, health and redistribution? A systematic review of the empirical evidence from 1990 to 2011. Eur J Health Econ 2014;15:813-28.
38. Hynd A, Roughead EE, Preen DB, et al. The impact of co-payment increases on dispensings of government-subsidised medicines in Australia. Pharmacoepidemiol Drug Saf 2008;17:1091-9.
39. Hsu J, Price M, Huang J, et al. Unintended consequences of caps on Medicare drug benefits. N Engl J Med 2006;354:2349-59.
40. Mojtabai R, Olfson M. Medication costs, adherence, and health outcomes among Medicare beneficiaries. Health Affairs 2003;22:220-9.
41. Heisler M, Langa KM, Eby EL, et al. The health effects of restricting prescription medication use because of cost. Med Care 2004;42:626-34.
42. Piette JD, Rosland AM, Silveira MJ, et al. Medication cost problems among chronically ill adults in the US: did the financial crisis make a bad situation even worse. Patient Prefer Adherence 2011;5:187-94.
43. Trans Pacific Partnership. Intellectual Property [Rights] Chapter: Consolidated Text. Ho Chi Minh Round-May 16, 2014. [Leaked draft text]. Ho Chi Minh Round-May 16, 2014. [Leaked draft text]. 2014. https://wikileaks.org/tpp-ip2/tpp-ip2-chapter.pdf.
44. Trans Pacific Partnership. Transparency chapter-annex on transparency and procedural fairness for healthcare technologies [Leaked draft text]. 2011. http://www.citizenstrade.org/ctc/wp-content/uploads/2011/10/TransPacificTransparency.pdf.
45. Trans Pacific Partnership. Investment chapter [Leaked draft text]. 2012. http://www.citizenstrade.org/ctc/wp-content/uploads/2012/06/tppinvestment.pdf.
46. Hirono K, Haigh F, Gleeson D, et al. Negotiating healthy trade in Australia: health impact assessment of the proposed Trans-Pacific Partnership Agreement. Liverpool, NSW: Centre for Health Equity Training Research tand Evaluation, part of the Centre for Primary Health Care and Equity, UNSW Australia, 2015.
47. Lopert R, Gleeson D. The high price of "free" trade: U.S. trade agreements and access to medicines. J Law Med Ethics 2013;41:199-223.
48. Flynn S, Baker B, Kaminski M, et al. The U.S. Proposal for an Intellectual Property Chapter in the Trans-Pacific Partnership Agreement. American University International Law Review. 2012;28:105-202.
49. Médecins Sans Frontières. Trading Away Health: The Trans-Pacific Partnership Agreement (TPP). 2013. http://www.doctorswithoutborders.org/publications/reports/2013/Access-Briefing-TPP-ENG-2013.pdf.
50. Clarke H, Prentice D. Will plain packaging reduce cigarette consumption? Economic papers. J Appl Econ Policy 2012;31:303-17.
51. AIHW (Australian Institute of Health and Welfare). 2010 National drug strategy household survey report. 2011. http://www.aihw.gov.au/WorkArea/DownloadAsset.aspx?id=10737421314.
52. ABS (Australian Bureau of Statistics). Australian Health Survey: first results, 2011-12. Canberra: ABS, 2012.
53. Tobacco Working Group. The Healthiest country by 2020, Technical Report 2, Tobacco Control in Australia: making smoking history. Australia: National Preventative Health Taskforce, 2009.
54. Hammond D, Fong GT, McDonald PW, et al. Impact of the graphic Canadian warning labels on adult smoking behaviour. Tob Control 2003;12:391-5.
55. Azagba S, Sharaf MF. The effect of graphic cigarette warning labels on smoking behavior: evidence from the Canadian experience. Nicotine Tob Res 2013;15:708-17.
56. Hammond D, Fong GT, McNeill A, et al. Effectiveness of cigarette warning labels in informing smokers about the risks of smoking: findings from the International Tobacco Control (ITC) Four Country Survey. Tob Control 2006;15(Suppl 3):19-25.
57. Moodie CS, Mackintosh AM. Young adult women smokers' response to using plain cigarette packaging: A naturalistic approach. BMJ Open 2013;3:pii: e002402.
58. Wakefield MA, Hayes L, Durkin S, et al. Introduction effects of The Australian plain packaging policy on adult smokers: A cross-sectional study. BMJ Open 2013;3:pii: e003175.
59. Hammond D, Dockrell M, Arnott D, et al. Cigarette pack design and perceptions of risk among UK adults and youth. Eur J Public Health 2009;19:631-7.
60. Quit Victoria. Plain packaging of tobacco products: A review of the evidence. Cancer Council Victoria, 2011.
61. Indigenous and Remote Health Division, Australian Department of Health. Aboriginal and Torres Strait Islander Health Performance Framework (HPF). 2012. http://www.health.gov.au/internet/publications/publishing.nsf/Content/oatsih-hpf-2012-toc~tier2~hlthbeh~215.
62. Kermode M, Crofts N, Miller P, et al. Health indicators and risks among people experiencing homelessness in Melbourne, 1995- 1996. Aust N Z J Public Health 1998;22:464-70.
63. Stafford J, Sindicich N, Burns L, et al. Australian Drug Trends 2008: Findings from the Illicit Drug Reporting Systems (IDRS). Sydney: National Drug and Alcohol Research Centre, University of New South Wales, 2009.
64. Australian Institute of Health and Welfare. The health of Australia's prisoners 2010. Canberra: AIHW; 2011.
65. AIHW (Australian Institute of Health and Welfare). Drugs in Australia 2010: Tobacco, alcohol and other drugs. Drug statistics series, ed. Canberra: AIHW, 2011.
66. Australian Bureau of Statistics. National survey of mental health and wellbeing: summary of results, 2007. Canberra: ABS; 2008. ABS publication 4326.0.
67. Australian Institute of Health and Welfare. 2010 National drug strategy household survey report. Canberra: AIHW, 2011.
68. Trans Pacific Partnership. Trans-Pacific Partnership (TPP) Regulatory Coherence [Leaked draft text]. 2010. http://www.citizenstrade.org/ctc/wp-content/uploads/2011/10/TransPacificRegulatoryCoherence.pdf.
69. Kelsey J. New-generation free trade agreements threaten progressive tobacco and alcohol policies. Addiction 2012;107:1719-21.
70. Kelsey J. The Trans-Pacific Partnership agreement: A gold-plated gift to the global tobacco industry? Am J Law Med 2013;39:237-64.
71. Porterfield M, Byrnes C. Philip Morris v. Uruguay: Will investor-State arbitration send restrictions on tobacco marketing up in smoke? Investment Treaty News [newspaper online]. 12 July, 2011. Available from: http://www.iisd.org/itn/2011/07/12/philip-morris-v-uruguay-willinvestor-state-arbitration-send-restrictions-on-tobacco-marketing-upin-smoke/.
72. Fooks G, Gilmore AB. International trade law, plain packaging and tobacco industry political activity: The Trans-Pacific Partnership. Tob Control 2014;23:e1.
73. Stumberg R. Safeguards for tobacco control: options for the TPPA. Am J Law Med 2013;39:382-441.
74. Anderson P, Chisholm D, Fuhr DC. Effectiveness and cost effectiveness of policies and programmes to reduce the harm caused by alcohol. Lancet 2009;373:2234-46.
75. Martineau F, Tyner E, Lorenc T, et al. Population-level interventions to reduce alcohol-related harm: An overview of systematic reviews. Prev Med 2013;57:278-96.
76. Cobiac L, Vos T, Doran C, et al. Cost-effectiveness of interventions to prevent alcohol-related disease and injury in Australia. Addiction 2009;104:1646-55.
77. Blewett N. Labelling Logic: review of food labelling law and policy (2011). Department of Health and Ageing, 2011.
78. AIHW (Australian Institute of Health and Welfare). National Drug Strategy Household Survey 2013. Canberra, AIHW, 2013.
79. Jones SC, Gordon R. Regulation of alcohol advertising: Policy options for Australia. Evidence Base 2013;2:1-37.
80. Livingston M, Chikritzhs T, Room R, et al. Changing the density of alcohol outlets to reduce alcohol-related problems. Drug Alcohol Rev 2007;26:557-66.
81. O'Brien PL, Gleeson DH. Retaining our right to regulate alcohol warnings. Med J Aust 2013;199:447-7.
82. Kelly B, Hughes C, Chapman K, et al. Consumer testing of the acceptability and effectiveness of front-of-pack food labelling systems for the Australian grocery market. Health Promot Int 2009;24:120-9.
83. Chapman K. Out with traffic lights, in with stars-next steps for food labelling. http://www.cancercouncil.com.au/65841/news-media/blog/healthy-living-cancer-prevention/out-with-traffic-lights-in-with-stars-%E2%80%93-next-steps-for-food-labelling-by-kathy-chapman/.
84. Campos S, Doxey J, Hammond D. Nutrition labels on pre-packaged foods: A systematic review. Public Health Nutr 2011;14: 1496-506.
85. World Health Organization (WHO). Global strategy, on diet, physical activity and health. World Health Organization, 2004.
86. Ford PB, Dzewaltowski DA. Disparities in obesity prevalence due to variation in the retail food environment: Three testable hypotheses. Nutr Rev 2008;66:216-28.
87. Australian National Preventative Health Agency. Promoting a healthy Australia: Smoking and disadvantage [evidence brief ]. Canberra: ANPHA; 2013.
88. Yeatman H, van der Want E. Food labelling and its influences on food choices [evidence brief ]. Deakin: Deeble Institute for Health Policy Research; 2012 p. 1-6. Available from:https://ahha.asn.au/sites/default/files/docs/policy-issue/20120615-deeble-institute-evidence-brief-food-labelling.pdf.
89. Public Health Association of Australia. Report finds medicine affordability, public health policies at risk in Trans Pacific Partnership [media release] 3 March 2015. https://www.phaa.net.au/documents/item/512.
90. Drysdale K. Trans-Pacific Partnership-how do we make sense of the TPP secret negotiations? ABC, 2015.
91. Brisbane Times. Trans Pacific Partnership poses grim risks: Fairfax Media [newspaper online], 3 March 2015. http://www.brisbanetimes.com.au/video/video-news/video-federal-politics/trans-pacificpartnership-poses-grim-risks-20150302-3rb85.
92. Senator Wyden (OR). On introduction of the Congressional Oversight of Trade Negotiations Act. Congressional Record 66 (23 May 2012) p S3517. http://thomas.loc.gov/cgi-bin/query/D?r112:66:./temp/∼r1129vJddO.
93. Kehoe J. US, Australia drug dispute is holding up settlement of the Trans Pacific Trade Deal. Australia Financial Review 2015 4 Oct. http://www.afr.com/news/politics/national/us-australia-drug-dispute-isholding-up-settlement-of-the-trans-pacific-trade-deal-20151003-gk0r65.
94. Department of Foreign Affairs and Trade (DFAT). Trans-Pacific Partnership Agreement Outcomes: Health. 2016. http://dfat.gov.au/trade/agreements/tpp/outcomes-documents/Pages/outcomes-health.Aspx.
95. Gleeson D. Biologics provisions in the final TPP text. 2015. http://itsourfuture.org.nz/wp-content/uploads/2015/11/Biologics-provisionsin-the-final-TPP-text.pdf.
96. Kawharu A. Expert Paper #2 TPPA: Chapter 9 on Investment. 2015. https://tpplegal.files.wordpress.com/2015/12/ep2-amokura-kawharu.pdf.
97. Johnson L, Sachs L. The TPP's Investment Chapter: Entrenching, Rather than Reforming, a Flawed System. http://ccsi.columbia.edu/2015/11/18/the-tpps-investment-chapter-entrenching-rather-thanreforming-a-flawed-system/.